文献速递系统性红斑狼疮

增殖性肾小球肾炎病史预测纯膜性狼疮肾炎进展至终末期肾病

History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

该研究纳入至少接受两次临床指征肾活检的狼疮肾炎患者,探讨纯膜性(V型)狼疮肾炎中病理类型转换史对预后的价值。结果显示纯V型与增殖型之间转换频繁,首次活检为增殖性LN是重复活检为纯V型患者新发ESKD的预测因素。

要点

  • 纯V型与增殖型狼疮肾炎之间可相互转换,转换可发生于病程任何时间。
  • 重复活检为纯V型的患者中,首次活检为增殖性LN者新发ESKD风险更高。
  • 首次肾活检的病理分型对纯膜性LN的预后判断价值有限。

核心结论

  • 增殖性与膜性狼疮肾炎之间的转换在SLE中常见,可发生于病程任何时间,限制了首次活检的预后价值。
  • 既往增殖性LN证据是非增殖性LN患者发生ESKD的关键预测因素。

研究设计与样本

  • 纳入至少两次临床指征肾活检的狼疮肾炎患者共220例(542次活检),199例(90%)为女性,118例(54%)为非裔美国人,59例(27%)为白种人,首次肾活检中位年龄28岁。
  • 新发ESKD定义为估算肾小球滤过率<15 ml/min/1.73 m2、开始透析或肾移植。

主要发现

  • 首次活检为纯V型的患者中41%转换为增殖性LN。
  • 重复活检为纯V型的患者中52%此前有增殖性LN。
  • 对最多四次重复活检的轨迹分析显示ISN分型转换可发生于任何时间,甚至在多次相同分型活检之后。
  • 重复活检为纯V型的56例患者中5例(9%)在2年内新发ESKD,且这5例首次活检均为增殖性LN(log rank P = 0.024)。

临床怎么用

  • 对纯膜性狼疮肾炎患者应追溯既往肾活检史,明确是否存在增殖性LN病史以评估ESKD风险。
  • 不宜仅依据首次肾活检分型判断纯膜性LN的预后,必要时考虑重复活检。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pure membranous (class V) LN is considered a less aggressive phenotype, but tissue fibrosis and chronic kidney disease may still develop. This study aimed to elucidate the prognostic value of a history of class switch in pure membranous LN. METHODS: We included LN patients with at least two clinically indicated kidney biopsies. New onset of end stage kidney disease (ESKD) was defined as estimated glomerular filtration rate <15 ml/min/1.73 m2, initiation of dialysis or kidney transplantation. RESULTS: Among 220 patients (542 biopsies), 199 (90%) were female, and 118 (54%) were African American, 59 (27%) Caucasian, with median age of 28 years at the first kidney biopsy. Patients with pure class V in a first biopsy converted to proliferative LN in 41% of cases. Pure class V in a repeat biopsy was preceded by proliferative LN in 52%. Trajectory analysis of up to four repeat biopsies revealed that ISN class switch may happen at any time, even after multiple biopsies with the same class. New onset ESKD was observed within 2 years in 5/56 (9%) patients with pure class V in a repeat biopsy. All five patients had proliferative LN in the first biopsy (log rank P = 0.024). CONCLUSIONS: The conversion from proliferative to membranous (and vice-versa) is frequent in SLE. It can occur at any time in the course of disease, limiting the prognostic value of the first biopsy. Evidence of prior proliferative LN is key as it is associated with higher risk of ESKD in non-proliferative LN.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Fava A, Fenaroli P, Rosenberg A, et al. History of proliferative glomerulonephritis predicts end stage kidney disease in pure membranous lupus nephritis. Rheumatology (Oxford). 2022. PMID: 34664621. doi:10.1093/rheumatology/keab775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。